300 related articles for article (PubMed ID: 18042615)
1. Sirolimus ameliorates the enhanced expression of metalloproteinases in a rat model of autosomal dominant polycystic kidney disease.
Berthier CC; Wahl PR; Le Hir M; Marti HP; Wagner U; Rehrauer H; Wüthrich RP; Serra AL
Nephrol Dial Transplant; 2008 Mar; 23(3):880-9. PubMed ID: 18042615
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of mTOR with sirolimus slows disease progression in Han:SPRD rats with autosomal dominant polycystic kidney disease (ADPKD).
Wahl PR; Serra AL; Le Hir M; Molle KD; Hall MN; Wüthrich RP
Nephrol Dial Transplant; 2006 Mar; 21(3):598-604. PubMed ID: 16221708
[TBL] [Abstract][Full Text] [Related]
3. Expression of matrix metalloproteinase (MMP)-2, MMP-14 and tissue inhibitor of matrix metalloproteinase (TIMP)-2 during bovine placentation and at term with or without placental retention.
Dilly M; Hambruch N; Shenavai S; Schuler G; Froehlich R; Haeger JD; Ozalp GR; Pfarrer C
Theriogenology; 2011 Apr; 75(6):1104-14. PubMed ID: 21247626
[TBL] [Abstract][Full Text] [Related]
4. Basement membrane remodeling in skeletal muscles of patients with limb ischemia involves regulation of matrix metalloproteinases and tissue inhibitor of matrix metalloproteinases.
Baum O; Ganster M; Baumgartner I; Nieselt K; Djonov V
J Vasc Res; 2007; 44(3):202-13. PubMed ID: 17337906
[TBL] [Abstract][Full Text] [Related]
5. Focal overexpression of collagen IV characterizes the initiation of epithelial changes in polycystic kidney disease.
Schäfer K; Bader M; Gretz N; Oberbäumer I; Bachmann S
Exp Nephrol; 1994; 2(3):190-5. PubMed ID: 7922272
[TBL] [Abstract][Full Text] [Related]
6. [Effect of a modified low protein and low fat diet on histologic changes and metabolism in kidneys in an experimental model of polycystic kidney disease].
Banković-Calić N; Ogbori MR; Nicman E
Srp Arh Celok Lek; 2002; 130(7-8):251-7. PubMed ID: 12585002
[TBL] [Abstract][Full Text] [Related]
7. Rapamycin markedly slows disease progression in a rat model of polycystic kidney disease.
Tao Y; Kim J; Schrier RW; Edelstein CL
J Am Soc Nephrol; 2005 Jan; 16(1):46-51. PubMed ID: 15563559
[TBL] [Abstract][Full Text] [Related]
8. Effects of benazepril on renal function and kidney expression of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 in diabetic rats.
Sun SZ; Wang Y; Li Q; Tian YJ; Liu MH; Yu YH
Chin Med J (Engl); 2006 May; 119(10):814-21. PubMed ID: 16732983
[TBL] [Abstract][Full Text] [Related]
9. Mitotic activation of Akt signalling pathway in Han:SPRD rats with polycystic kidney disease.
Wahl PR; Le Hir M; Vogetseder A; Arcaro A; Starke A; Waeckerle-Men Y; Serra AL; Wuthrich RP
Nephrology (Carlton); 2007 Aug; 12(4):357-63. PubMed ID: 17635750
[TBL] [Abstract][Full Text] [Related]
10. Cyclosporine A inhibits the expression of membrane type-I matrix metalloproteinase in gingiva.
Chiu HC; Lu YT; Chin YT; Tu HP; Chiang CY; Gau CH; Nieh S; Fu E
J Periodontal Res; 2009 Jun; 44(3):338-47. PubMed ID: 19210333
[TBL] [Abstract][Full Text] [Related]
11. Modified synthetic siRNA targeting tissue inhibitor of metalloproteinase-2 inhibits hepatic fibrogenesis in rats.
Hu YB; Li DG; Lu HM
J Gene Med; 2007 Mar; 9(3):217-29. PubMed ID: 17351970
[TBL] [Abstract][Full Text] [Related]
12. Everolimus retards cyst growth and preserves kidney function in a rodent model for polycystic kidney disease.
Wu M; Wahl PR; Le Hir M; Wackerle-Men Y; Wuthrich RP; Serra AL
Kidney Blood Press Res; 2007; 30(4):253-9. PubMed ID: 17596700
[TBL] [Abstract][Full Text] [Related]
13. Macrophage-derived MT1-MMP and increased MMP-2 activity are associated with glomerular damage in crescentic glomerulonephritis.
Hayashi K; Horikoshi S; Osada S; Shofuda K; Shirato I; Tomino Y
J Pathol; 2000 Jul; 191(3):299-305. PubMed ID: 10878552
[TBL] [Abstract][Full Text] [Related]
14. Expression of matrix metalloproteinase-2 and -14 persists during early resolution of experimental liver fibrosis and might contribute to fibrolysis.
Zhou X; Hovell CJ; Pawley S; Hutchings MI; Arthur MJ; Iredale JP; Benyon RC
Liver Int; 2004 Oct; 24(5):492-501. PubMed ID: 15482348
[TBL] [Abstract][Full Text] [Related]
15. Altered ATP-sensitive P2 receptor subtype expression in the Han:SPRD cy/+ rat, a model of autosomal dominant polycystic kidney disease.
Turner CM; Ramesh B; Srai SK; Burnstock G; Unwin RJ
Cells Tissues Organs; 2004; 178(3):168-79. PubMed ID: 15655334
[TBL] [Abstract][Full Text] [Related]
16. Upregulation of tissue inhibitor of metalloproteases-1 (TIMP-1) and procollagen-N-peptidase in hypertension-induced renal damage.
Hultström M; Leh S; Skogstrand T; Iversen BM
Nephrol Dial Transplant; 2008 Mar; 23(3):896-903. PubMed ID: 17977875
[TBL] [Abstract][Full Text] [Related]
17. Expression of matrix metalloproteinase-9 associated with ets-1 proto-oncogene in rat tubulointerstitial cells.
Naito T; Tanihata Y; Nishimura H; Tanaka T; Higuchi C; Taguchi T; Sanaka T
Nephrol Dial Transplant; 2005 Nov; 20(11):2333-48. PubMed ID: 16046515
[TBL] [Abstract][Full Text] [Related]
18. Tissue inhibitor of metalloproteinase-1 exacerbated renal interstitial fibrosis through enhancing inflammation.
Cai G; Zhang X; Hong Q; Shao F; Shang X; Fu B; Feng Z; Lin H; Wang J; Shi S; Yin Z; Chen X
Nephrol Dial Transplant; 2008 Jun; 23(6):1861-75. PubMed ID: 18326884
[TBL] [Abstract][Full Text] [Related]
19. Dietary soy protein selectively reduces renal prostanoids and cyclooxygenases in polycystic kidney disease.
Peng CY; Sankaran D; Ogborn MR; Aukema HM
Exp Biol Med (Maywood); 2009 Jul; 234(7):737-43. PubMed ID: 19429858
[TBL] [Abstract][Full Text] [Related]
20. Differential expression of matrix metalloproteinases and tissue inhibitors and extracellular matrix remodeling in aortic regurgitant hearts.
Truter SL; Catanzaro DF; Supino PG; Gupta A; Carter J; Herrold EM; Dumlao TF; Borer JS
Cardiology; 2009; 113(3):161-8. PubMed ID: 19129699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
